Director, Health Economic Outcomes Research (Remote)
IlluminaFull Time
Expert & Leadership (9+ years)
Candidates should possess a B.S. in life science, biology, business, or marketing, with an MBA preferred. A proven track record of revenue generation in diagnostics, pharmaceuticals, or biotechnology is essential, along with at least 3 years of direct account management experience in molecular diagnostics, ideally with a focus on MRD testing. Experience working with major cancer centers, oncology GPOs, large health systems, and oncology practices is required. The role demands proven ability to sell integrated molecular diagnostic solutions and engage in consultative selling, comfort in interacting with executive-level stakeholders, and an in-depth understanding of the payer and reimbursement environment in oncology diagnostics. Strong independent work ethic with excellent communication, project management, and prioritization skills, combined with knowledge of molecular diagnostics, MRD testing, and the competitive landscape in oncology, are necessary. Proficiency in Microsoft Office (Excel, PowerPoint) and Salesforce.com, along with the ability to develop cross-functional relationships, advanced presentation skills, business acumen, and the capacity to work effectively with minimal direction, are also required.
The MRD Clinical Account Executive is responsible for driving the adoption of Tempus's MRD testing services within their assigned territory, which includes major U.S. cancer centers, health systems, and community practices. This involves engaging with Key Opinion Leaders (KOLs), clinicians, and decision-makers to establish and expand business opportunities, and developing strategic plans for acquiring new clients and retaining existing ones while maximizing client-bill contracting opportunities. The role includes implementing laboratory services agreements (LSAs) for client billing, collaborating with various sales roles within Tempus to achieve company goals, and identifying/developing partnership opportunities between oncology clients and Tempus to promote MRD testing integration. The executive will provide feedback to Tempus leadership based on market analysis and competitive landscape, and develop and implement a comprehensive business plan for the territory, including budgets, travel, territory management, and goal setting. They will also represent Tempus's company culture with integrity, respect, and trust to all stakeholders.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.